Chiong E

ORCID: 0000-0002-5241-5000 · 1 paper in corpus
2020
Clinical studies investigating the use of leuprorelin for prostate cancer in Asia.
Prostate international ·doi:10.1016/j.prnil.2019.06.001

BackgroundLeuprorelin is a well-established treatment for prostate cancer (PCa); however, there is limited information on its use in Asian males. This review of English language publications between January 2000 and 2016 describes the outco…